106 |
Percutaneous Pulmonary Valve Replacement: State of the Art |
Damien Kenny |
Apr. 21. 16 |
105 |
Where Are We with PFO Closure? Long-Term Outcome from Randomized Trials |
Damien Kenny |
Apr. 21. 16 |
104 |
Initial Experience with a Bioresorbable ASD/PFO Occluder |
Horst Sievert |
Apr. 21. 16 |
103 |
ASD Closure Using Gore Cardioform Septal Occludet |
Neil Wilson |
Apr. 21. 16 |
102 |
Cardiovascular Complications of ASD Closure: Japanese Experiences |
Teiji Akagi |
Apr. 21. 16 |
101 |
PFO Closure for Prevention of Cryptogenic Stroke: What Is the Final Word? |
Issam D. Moussa |
Apr. 21. 16 |
100 |
Balloon Angioplasty in CTEPH |
Hiromi Matsubara |
Apr. 21. 16 |
99 |
Current Procedural Recommendations of Renal Denervation in 2016 |
Horst Sievert |
Apr. 21. 16 |
98 |
LAA Occlusion in Korean Multicenter Registry |
Jung-Sun Kim |
Apr. 21. 16 |
97 |
WATCHMAN Device Versus NOAC (New Oral Anticoagulant) Drugs |
Ted Feldman |
Apr. 21. 16 |